Research

Hormonal

Liraglutide improves beta-cell function (HOMA-S) in patients with type 2 diabetes, as indicated by a significant increase in HOMA-S compared to placebo.

This treatment helps your pancreas work better at producing insulin in response to blood sugar levels, which is a key factor in managing type 2 diabetes.

GoodSupportsHIGH confidence
Liraglutide treatment suggested an improved beta-cell function compared with placebo as indicated by increased HOMA-S (liraglutide, 17.2%, and placebo, -15.2%; P = 0.015)
Helle Harder et al. · Diabetes Care · 2004

Why this rating

Statistically significant result from a randomized controlled trial.

Source

The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes

Helle Harder et al. · Diabetes Care · 2004

DOI 10.2337/diacare.27.8.1915

rct · n=33Cited 225×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →